Literature DB >> 18245957

Identification of candidate biomarkers for hepatocellular carcinoma through pre-cancerous expression analysis in an HBx transgenic mouse.

Qiang Sun1, Yingai Zhang, Fang Liu, Xiaohang Zhao, Xiao Yang.   

Abstract

The aim of this study is to identify candidate biomarkers for the detection of hepatocellular carcinoma (HCC) through pre-cancerous gene expression analysis in an HBx transgenic mouse model. The gene expression profiles of liver and tumor tissues from 6-, 12- and 18-month-old HBx transgenic and littermate control mice were monitored using DNA oligo microarrays. Data analysis revealed changes in 684 genes in the tumor tissues from HBx transgenic mice. Based on their pre-cancerous expression profiles, two separate gene groups, corresponding to HCC specific and non-specific groups respectively, were identified. Gene ontology analysis identified 47 genes encoding secretory or transmembrane proteins among 155 upregulated genes in the HCC-specific group. Among these, four genes encoding TFF3, IGF2, LPL and SPP1 were found to be promising biomarker candidates for the detection of HCC as compared with AFP. This work describes a new way to identify novel biomarker candidates for HCC diagnosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18245957     DOI: 10.4161/cbt.6.10.4683

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  12 in total

1.  Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.

Authors:  Ming-Liang You; Yi-Jun Chen; Qing-Yun Chong; Ming-Ming Wu; Vijay Pandey; Ru-Mei Chen; Liang Liu; Lan Ma; Zheng-Sheng Wu; Tao Zhu; Peter E Lobie
Journal:  Oncotarget       Date:  2017-06-13

Review 2.  Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer.

Authors:  Martha L Peterson; Chunhong Ma; Brett T Spear
Journal:  Semin Cancer Biol       Date:  2011-01-07       Impact factor: 15.707

3.  Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients.

Authors:  Zi-Li He; He Zheng; Hui Lin; Xiong-Ying Miao; De-Wu Zhong
Journal:  World J Gastroenterol       Date:  2009-09-07       Impact factor: 5.742

4.  Differential reactivation of fetal/neonatal genes in mouse liver tumors induced in cirrhotic and non-cirrhotic conditions.

Authors:  Xi Chen; Masahiro Yamamoto; Kiyonaga Fujii; Yasuharu Nagahama; Takako Ooshio; Bing Xin; Yoko Okada; Hiroyuki Furukawa; Yuji Nishikawa
Journal:  Cancer Sci       Date:  2015-06-25       Impact factor: 6.716

5.  Development of a High-Throughput Molecular Imaging-Based Orthotopic Hepatocellular Carcinoma Model.

Authors:  Gloria L Hwang; Maurice A van den Bosch; Young I Kim; Regina Katzenberg; Juergen K Willmann; Ramasamy Paulmurugan; Sanjiv S Gambhir; Lawrence Hofmann
Journal:  Cureus       Date:  2015-06-27

6.  Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma.

Authors:  Qing-Yun Chong; Ming-Liang You; Vijay Pandey; Arindam Banerjee; Yi-Jun Chen; Han-Ming Poh; Mengyi Zhang; Lan Ma; Tao Zhu; Salundi Basappa; Liang Liu; Peter E Lobie
Journal:  Oncotarget       Date:  2017-06-09

7.  The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.

Authors:  Chenghua Zhang; Ran Xia; Bo Zhang; Haibo Wang
Journal:  BMC Cancer       Date:  2018-11-13       Impact factor: 4.430

8.  Transforming growth factor-beta-regulated miR-24 promotes skeletal muscle differentiation.

Authors:  Qiang Sun; Yan Zhang; Guang Yang; Xiaoping Chen; Yingai Zhang; Guojun Cao; Jian Wang; Yanxun Sun; Peng Zhang; Ming Fan; Ningsheng Shao; Xiao Yang
Journal:  Nucleic Acids Res       Date:  2008-03-19       Impact factor: 16.971

9.  Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells.

Authors:  Vijay Pandey; Min Zhang; Qing-Yun Chong; Mingliang You; Ainiah Rushdiana Raquib; Amit K Pandey; Dong-Xu Liu; Liang Liu; Lan Ma; Sudhakar Jha; Zheng-Sheng Wu; Tao Zhu; Peter E Lobie
Journal:  Oncotarget       Date:  2017-08-24

10.  The perplexity of targeting genetic alterations in hepatocellular carcinoma.

Authors:  Michele Barone; Alfredo Di Leo; Carlo Sabbà; Antonio Mazzocca
Journal:  Med Oncol       Date:  2020-07-22       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.